[1] INO Y, GOTOH M, SAKAMOTO M. dysadherin,a cancer-associated cell membrane glycoprotein,down-regulates E-cadherin and promotes metastasis. 2002(1)
[2] TSUIJI H, TAKASAKI S, SAKAMOTO M. Aberrant O-glycosylation inhibits stable expression of dysadherin,a carcinoma-associated antigen,and facilitates cell adhesion. 2003(7). doi:10.1093/glycob/cwg065
[3] SHIMAMURA T, YASUDA J, INO Y. dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells. 2004(19). doi:10.1158/0008-5472.CAN-04-1166
[4] SHIMAMURA T, SAKAMOTO M, INO Y. dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness:relationship to E-cadherin expression. 2003(4). doi:10.1200/JCO.2003.06.179
[5] SHIMADA Y, YAMASAKI S, HASHIMOTO Y. Clinical significance of dysadherin expression in gastric cancer patients. 2004(8). doi:10.1158/1078-0432.CCR-0633-03
[6] SATO H, INO Y, MIURA A. dysadherin:expression and clinical significance in thyroid carcinoma, [外文会议] 2003(9)
[7] WU D, QIAO Y, KRISTENSEN G B. Prognostic significance of dysadherin expression in cervical squamous cell carcinoma, 2004(4)
[8] AOKI S, SHIMAMURA T, SHIBATA T. Prognostic significance of dysadherin expression in advanced colorectal carcinoma. 2003(5). doi:10.1038/sj.bjc.6600778
[9] TAMURA M, OHTA Y, TSUNEZUKA Y. Prognostic significance of dysadherin expression in patients with non small cell lung cancer. 2005(3). doi:10.1016/j.jtcvs.2004.12.051
[10] NISHIZAWA A, NAKANISHI Y, YOSHIMURA K. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma:immunohistochemical analysis of 115 patients. 2005(8). doi:10.1002/cncr.20984
[11] NAKANISHI Y, AKIMOTO S, SATA Y. Prognostic significance of dysadherin expression in tongue cancer:immunohistochemical analysis of 91 cases. 2004(4). doi:10.1097/00129039-200412000-00006
[12] KYZAS P A, STEFANOU D, BATISTATOU A. dysadherin expression in head and neck squamous cell carcinoma:association with lymphangiogenesis and prognostic significance. 2006(2). doi:10.1097/01.pas.0000178090.54147.f8
[13] RIMM D L, KOSLOV E R, KEBRIAEI P. α1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex, 1995(19)
[14] NAM J S, KANG M J, SUCHAR A M. Chemokine (C-C Motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. 2006(14). doi:10.1158/0008-5472.CAN-06-0825 |
